LPL Financial Welcomes Advisor Philip Nation
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Philip Nation, CFP®, ChFC™, […]
Verizon Frontline to showcase mission-critical communications solutions at FDIC International 2024
INDIANAPOLIS, April 15, 2024 (GLOBE NEWSWIRE) — The 2024 Fire Department Instructors Conference International kicks off today at the Indiana […]
TSX News -
Haivision Announces Interoperability with Sony’s Cloud Production Platform, Creators’ Cloud for Enterprise
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) — Haivision Systems Inc. (“Haivision”) (TSX: HAI), a leading global provider of mission-critical, real-time […]
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced that Charles Lapp, MD, […]
Brandywine Realty Trust Announces Tender Offer for Any and All of its Outstanding 4.10% Guaranteed Notes due 2024
PHILADELPHIA, April 15, 2024 (GLOBE NEWSWIRE) — Brandywine Realty Trust (the “Company”) (NYSE:BDN) announced today that its operating partnership, Brandywine […]
HeartCore Signs 14th Go IPO Contract
NEW YORK and TOKYO, April 15, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic […]
TOMI Environmental Solutions to Attend Interphex 2024
FREDERICK, Md., April 15, 2024 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in […]
CONTEXTLOGIC VOTE UPDATE: Less Than 350,000 Shares Needed to Approve the Proposed Transaction with Qoo10
SAN FRANCISCO, April 15, 2024 (GLOBE NEWSWIRE) — ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) today mailed a […]
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare […]
